
Medical device maker Solventum's SOLV.N shares rise 1.8% to $77.67 premarket
Co says Thermo Fisher TMO.N will buy its purification and filtration business for about $4.1 billion in cash
The transaction is expected to be completed by the end of 2025
Up to last close, SOLV down 4.7% since close on March 26, 2024, after spin off from 3M